Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

NEUROD1 and Monogenic Diabetes

Monogenic diabetes (MONDO:0015967) due to NEUROD1 variants (MODY6) has been reported in a small number of unrelated families and probands, consistent with an autosomal dominant inheritance pattern. Two heterozygous NEUROD1 mutations were identified in autoantibody‐negative pediatric diabetes cohorts: a frameshift variant c.617dup (p.His206GlnfsTer) in one proband detected by targeted NGS (10.5% of autoantibody‐negative subjects) (PMID:35769090) and a missense mutation c.317C>T (p.Ala106Val) in a Chinese MODY6 case report (PMID:40026692). Segregation of a novel p.Ser159Pro variant in one family co-segregated with diabetes in four additional affected relatives (PMID:17440689). No NEUROD1 mutations were found in a diagnostic screen of 73 Norwegian MODYX probands and 51 gestational diabetes subjects, indicating mutation rarity and low prevalence in some populations (PMID:16026366).

Functional studies demonstrate that NEUROD1 acts as a key regulator of insulin gene transcription and β-cell differentiation. Chromatin immunoprecipitation and promoter assays confirmed direct NEUROD1 binding to the Ins2 promoter, and siRNA knockdown of Neuronatin (a NEUROD1 target) impaired glucose‐mediated insulin secretion in β‐cells (PMID:15793245). NEUROD1 interacts with PDX1 and MafA to modulate Ins2 expression, with loss-of-function reducing insulin mRNA in islet cells (PMID:19264802). Recent knockout models show Neurod1 deficiency disrupts endocrine lineage commitment, confirming a haploinsufficiency mechanism for neonatal diabetes and MODY (PMID:37689751).

References

  • Frontiers in endocrinology • 2025 • A case report of a MODY6 patient coexistence with Charcot-Marie-Toothe 1A syndrome. PMID:40026692
  • Journal unknown • Year unknown • Prevalence of monogenic diabetes in pediatric insulin-dependent patients PMID:35769090
  • Molecular and cellular biochemistry • 2007 • A novel mutation, Ser159Pro in the NeuroD1/BETA2 gene contributes to the development of diabetes in a Chinese potential MODY family. PMID:17440689
  • Diabetic medicine • 2005 • Diagnostic screening of NEUROD1 (MODY6) in subjects with MODY or gestational diabetes mellitus. PMID:16026366
  • Diabetes • 2005 • Neuronatin, a downstream target of BETA2/NeuroD1 in the pancreas, is involved in glucose-mediated insulin secretion. PMID:15793245
  • Nucleic acids research • 2009 • The Krüppel-like zinc finger protein Glis3 directly and indirectly activates insulin gene transcription PMID:19264802
  • Nature communications • 2023 • NEUROD1 reinforces endocrine cell fate acquisition in pancreatic development. PMID:37689751

Evidence Based Scoring (AI generated)

Gene–Disease Association

Limited

Three unrelated probands with heterozygous NEUROD1 variants, one family segregation, rarity across cohorts

Genetic Evidence

Limited

Three distinct NEUROD1 alleles in AD MODY6, segregation in a single family

Functional Evidence

Moderate

Direct insulin promoter activation, β-cell differentiation defects in KO models